實際療程效果依據個人體質條件而有差異,本資訊無法替代醫師親自問診,任何療程效果與風險均應以醫師親自診斷為主

 

1. Pourcho AM, Smith J, Wisniewski SJ, Sellon JL. Intraarticular platelet-richplasma injection in the treatment of knee osteoarthritis: review and

recommendations. Am J Phys Med Rehabil. 2014 Nov;93(11 Suppl 3):S108-21. doi:10.1097/PHM.0000000000000115. PMID: 24879553. https://www.ncbi.nlm.nih.gov/pubmed/24879553

 

2. Belk JW, Kraeutler MJ, Houck DA, Goodrich JA, Dragoo JL, McCarty EC. Platelet-Rich Plasma Versus Hyaluronic Acid for Knee Osteoarthritis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Am J Sports Med. 2021 Jan;49(1):249-260. doi: 10.1177/0363546520909397. Epub 2020 Apr 17. PMID: 32302218. https://pubmed.ncbi.nlm.nih.gov/32302218/

 

3. Aust M, Pototschnig H, Jamchi S, Busch KH. Platelet-rich Plasma for Skin Rejuvenation and Treatment of Actinic Elastosis in the Lower Eyelid Area. Cureus. 2018 Jul 18;10(7):e2999. doi: 10.7759/cureus.2999. PMID: 30515364; PMCID: PMC6260498. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260498/

 

4. Kamakura T, Kataoka J, Maeda K, Teramachi H, Mihara H, Miyata K, Ooi K, Sasaki N, Kobayashi M, Ito K. Platelet-Rich Plasma with Basic Fibroblast Growth Factor for Treatment of Wrinkles and Depressed Areas of the Skin. Plast Reconstr Surg. 2015 Nov;136(5):931-939. doi: 10.1097/PRS.0000000000001705. PMID: 26171752. https://pubmed.ncbi.nlm.nih.gov/26171752/

 

5. 衛生福利部106324日衛部醫字第1061662285號函有關醫療機構執行高濃度血小板血漿(PRP)之管理規範。

 

6. Taniguchi Y, Yoshioka T, Sugaya H, Gosho M, Aoto K, Kanamori A, Yamazaki M. Growth factor levels in leukocyte-poor platelet-rich plasma and correlations with donor age, gender, and platelets in the Japanese population. J Exp Orthop. 2019 Feb 2;6(1):4. doi: 10.1186/s40634-019-0175-7. PMID: 30712144; PMCID: PMC6359998. https://pubmed.ncbi.nlm.nih.gov/30712144/

 

arrow
arrow
    全站熱搜

    李冠穎醫師 發表在 痞客邦 留言(0) 人氣()